Re: Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Samir S. Taneja

doi:10.1016/j.juro.2012.01.105

Re: Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1585-1586
Number of pages	2
Journal	Journal of Urology
Volume	187
Issue number	5
DOIs	https://doi.org/10.1016/j.juro.2012.01.105
State	Published - May 2012

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2012.01.105

Cite this

Re: Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. / Taneja, Samir S.
In: Journal of Urology, Vol. 187, No. 5, 05.2012, p. 1585-1586.

Research output: Contribution to journal › Comment/debate › peer-review

@article{58caa2229c56471cad2b8dde8d1962fb,

title = "Re: Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986",

author = "Taneja, {Samir S.}",

year = "2012",

month = may,

doi = "10.1016/j.juro.2012.01.105",

language = "English (US)",

volume = "187",

pages = "1585--1586",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Re

T2 - Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

AU - Taneja, Samir S.

PY - 2012/5

Y1 - 2012/5

UR - http://www.scopus.com/inward/record.url?scp=84859522883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859522883&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.01.105

DO - 10.1016/j.juro.2012.01.105

M3 - Comment/debate

C2 - 22494714

AN - SCOPUS:84859522883

SN - 0022-5347

VL - 187

SP - 1585

EP - 1586

JO - Journal of Urology

JF - Journal of Urology

IS - 5

ER -

Re: Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this